Edgen Stock·Dec 12 2025, 01:45Back
Intuitive Surgical Navigates GLP-1 Drug Headwinds
Edgen Stock·Dec 12 2025, 01:45
[1] Lilly's next-gen drug tops Zepbound on weight loss in late-stage osteoarthritis trial - Reuters (https://www.reuters.com/business/healthcare-p ...)[2] Lilly’s Retatrutide Scores Triple Trial Triumph With 26% Weight Loss, But New Safety Signal Emerges - BioSpace (https://www.biospace.com/drug-development/lil ...)[3] Eli Lilly's next-generation obesity drug delivers strong weight loss, reduces knee pain in late-stage trial - cnbc.com (https://www.cnbc.com/2025/12/11/eli-lillys-we ...)
